CSF2 and myeloid sarcoma: In a cohort of persons with MS, the frequency of GM-CSF+ CD4+ memory T cells was significantly increased in the CSF as compared to the blood, with a lower and non-significant increase in the OND cohort (Fig. 3A,B).